Lipid Droplet Remodeling at the Glia–Neuron Interface: Metabolic Sinks, Flux Traps, and Therapeutic Pitfalls in Neurodegeneration

Neurodegenerative diseases are characterized by progressive neurological decline, metabolic dysfunction, and chronic neuroinflammatory changes. Dysregulated lipid handling has emerged as an important component of these processes, but the functional significance of lipid droplets (LDs) remains strongly context-dependent. Here, we review LD biogenesis, turnover, and cell type-specific functions in the central nervous system (CNS) and critically evaluate evidence linking LD remodeling to neurodegeneration. Transient LD formation can buffer excess or oxidation-prone lipids and support metabolic adaptation, whereas persistent lipid retention in the setting of impaired lysosomal, mitochondrial, or lipid-export capacity is associated with cellular dysfunction. We compare human tissue data, genetic evidence, LD-specific perturbations, pharmacological studies, and experimental models across Alzheimer’s disease (AD), Parkinson’s disease (PD), amyotrophic lateral sclerosis (ALS), and Huntington’s disease (HD). Particular attention is given to microglial lipid-associated states, neuron–glia lipid transfer, monogenic disorders of lipid handling, and apparently opposing outcomes of LD manipulation in different disease contexts. Rather than treating LD accumulation as a universal pathogenic mechanism, we propose LD remodeling as a candidate metabolic–inflammatory convergence state whose functional consequences depend on cell type, lipid composition, turnover capacity, and disease stage. Translational strategies should therefore prioritize direct measurements of LD flux, demonstration of CNS target engagement, and biomarker-guided patient and disease-stage selection. We further define experimental findings that would support or falsify the proposed convergence model.

Authors

Institutions

Publication Details

Journal
International Journal of Molecular Sciences
Published
2026-11-12
DOI
https://doi.org/10.3390/ijms272210141
Primary Topic
Lipid metabolism and biosynthesis
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Lipid Droplet Remodeling at the Glia–Neuron Interface: Metabolic Sinks, Flux Traps, and Therapeutic Pitfalls in Neurodegeneration

Guangyuan Hu, Xiaoxiao Luo, Yizhen Su, Min Fu
International Journal of Molecular Sciences
Lipid metabolism and biosynthesis
article

Lipid Droplet Remodeling at the Glia–Neuron Interface: Metabolic Sinks, Flux Traps, and Therapeutic Pitfalls in Neurodegeneration

Guangyuan Hu, Xiaoxiao Luo, Yizhen Su, Min Fu
article en

Abstract

Neurodegenerative diseases are characterized by progressive neurological decline, metabolic dysfunction, and chronic neuroinflammatory changes. Dysregulated lipid handling has emerged as an important component of these processes, but the functional significance of lipid droplets (LDs) remains strongly context-dependent. Here, we review LD biogenesis, turnover, and cell type-specific functions in the central nervous system (CNS) and critically evaluate evidence linking LD remodeling to neurodegeneration. Transient LD formation can buffer excess or oxidation-prone lipids and support metabolic adaptation, whereas persistent lipid retention in the setting of impaired lysosomal, mitochondrial, or lipid-export capacity is associated with cellular dysfunction. We compare human tissue data, genetic evidence, LD-specific perturbations, pharmacological studies, and experimental models across Alzheimer’s disease (AD), Parkinson’s disease (PD), amyotrophic lateral sclerosis (ALS), and Huntington’s disease (HD). Particular attention is given to microglial lipid-associated states, neuron–glia lipid transfer, monogenic disorders of lipid handling, and apparently opposing outcomes of LD manipulation in different disease contexts. Rather than treating LD accumulation as a universal pathogenic mechanism, we propose LD remodeling as a candidate metabolic–inflammatory convergence state whose functional consequences depend on cell type, lipid composition, turnover capacity, and disease stage. Translational strategies should therefore prioritize direct measurements of LD flux, demonstration of CNS target engagement, and biomarker-guided patient and disease-stage selection. We further define experimental findings that would support or falsify the proposed convergence model.

International Journal of Molecular SciencesVol. 27(22)
Tongji Hospital (CN), Huazhong University of Science and Technology (CN)
National Natural Science Foundation of China, China Postdoctoral Science Foundation
Good health and well-being
Lipid metabolism and biosynthesis
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon